GNU social JP
  • FAQ
  • Login
GNU social JPは日本のGNU socialサーバーです。
Usage/ToS/admin/test/Pleroma FE
  • Public

    • Public
    • Network
    • Groups
    • Featured
    • Popular
    • People

Embed Notice

HTML Code

Corresponding Notice

  1. Embed this notice
    BowserNoodle ☦️ (bowsacnoodle@poa.st)'s status on Tuesday, 28-Oct-2025 12:26:20 JSTBowserNoodle ☦️BowserNoodle ☦️
    in reply to
    • Branman65?
    • Zardoz
    • son of sam harris
    • ILoveBlueSky

    @Zardoz @branman65 @ILoveBlueSky @sam_harris The flu “vaccine” is the one that got me started. They publish the efficacy rates and it’s barely above placebo or has a wild range of efficacy (10-55%) with incredibly low confidence ratings in the data. Not to mention the proposed mechanism – if it actually worked as it’s supposed to and everybody got it, you’d just artificially select out for a different strain of flu and make the vaccine worthless.

    2017-2018 Season Efficacy Rates:

    • Children (6-17 years):
      • Influenza A (H1N1): 41.9% - 61.3% efficacy (95% confidence interval)
      • Influenza A (H3N2): 30.7% - 54.9% efficacy (95% confidence interval)
    • Adults (18-49 years):
      • Influenza A (H1N1): 35.4% - 49.4% efficacy (95% confidence interval)
      • Influenza A (H3N2): 17.6% - 41.1% efficacy (95% confidence interval)
    • Adults (50 years and older):
      • Influenza A (H1N1): 24.4% - 36.5% efficacy (95% confidence interval)
      • Influenza A (H3N2): 13.6% - 32.1% efficacy (95% confidence interval)
    In conversationabout 5 months ago from poa.stpermalink
  • Help
  • About
  • FAQ
  • TOS
  • Privacy
  • Source
  • Version
  • Contact

GNU social JP is a social network, courtesy of GNU social JP管理人. It runs on GNU social, version 2.0.2-dev, available under the GNU Affero General Public License.

Creative Commons Attribution 3.0 All GNU social JP content and data are available under the Creative Commons Attribution 3.0 license.